Yue Liu

7.0k citations
227 papers · 4.3k indexed · 5 hit papers · h-index 32
Topics
RNA modifications and cancer (25 papers)Ferroptosis and cancer prognosis (25 papers)Cancer, Lipids, and Metabolism (16 papers)

In The Last Decade

Yue Liu

207 papers receiving 4.2k citations

Hit Papers

The diversified role of mitochondria in ferroptosis ...20212026202220242023202120232023202350100150200

Peers

Yue Liu
Comparison fields: 5 of 156
  • Molecular Biology 2.2k
  • Cancer Research 984
  • Pulmonary and Respiratory Medicine 800
  • Oncology 715
  • Immunology 644
Replace Kang Li with:
Kang Li China
Andre Kajdacsy‐Balla United States
Hui‐Ling Chen Taiwan
Lin Li China
Xinwei Han China
Yan Li China
Yanyan Li China
Pengfei Xu China
Mingzhu Yin China
Yue Liu relative to Kang Li China Kang Li's profile →
Citations per field
00.5×2.8×
Kang Li · 1×
Citations per year

Countries citing papers authored by Yue Liu

Since Specialization
Citations

This map shows the geographic impact of Yue Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Liu more than expected).

Fields of papers citing papers by Yue Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Liu. The network helps show where Yue Liu may publish in the future.

Co-authorship network of co-authors of Yue Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Liu. A scholar is included among the top collaborators of Yue Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Liu. Yue Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 8
5 1
6 4
7 1
8 10
9 8
10 0
11 32
12 12
13 28
14 7
15 9
16 93
17
Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11breakdown →
187
18 8
19 13
20 256

About Yue Liu

Yue Liu is a scholar working on Research and Theory, Cancer Research and Oncology, having authored 227 papers that have together received 4.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (25 papers), Ferroptosis and cancer prognosis (25 papers) and Cancer, Lipids, and Metabolism (16 papers). The work is most often cited by research in Cancer Research (984 citations), Molecular Biology (2.2k citations) and Immunology (644 citations). Yue Liu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yufeng Shi, Jin Zhang, Lei‐Lei Wu, Shi-Ping Lu, Lixue Yang, Liang Yang, Mou‐Tuan Huang, Yanjin Wang, Yi Wang and Ah‐Ng Tony Kong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026